Joy Bessenger
Direttore Finanziario/CFO presso TRELLUS HEALTH PLC
Posizioni attive di Joy Bessenger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TRELLUS HEALTH PLC | Direttore Finanziario/CFO | 18/09/2023 | - |
Storia della carriera di Joy Bessenger
Precedenti posizioni note di Joy Bessenger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMV INC. | Contatto Relazioni con gli Investitori | 01/09/2021 | 11/06/2022 |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Public Communications Contact | 26/06/2009 | - |
Formazione di Joy Bessenger
| University of South Florida | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Islanda | 2 |
| Canada | 2 |
| Stati Uniti | 2 |
Posizioni
| Public Communications Contact | 1 |
| Investor Relations Contact | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IMV INC. | Health Technology |
| TRELLUS HEALTH PLC | Technology Services |
| Aziende private | 1 |
|---|---|
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
- Borsa valori
- Insiders
- Joy Bessenger
- Esperienza
